- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about BGNE
Recent news which mentions BGNE
2 Risky Growth Stocks That Could Make You Filthy Rich
January 16, 2022
From Motley Fool
From InvestorPlace
From Benzinga
46 Biggest Movers From Yesterday
December 16, 2021
From Benzinga
Why Shares of BeiGene and Zai Lab Are Tanking Today
December 15, 2021
From Motley Fool
36 Stocks Moving In Wednesday's Mid-Day Session
December 15, 2021
From Benzinga
From InvestorPlace
20 Stocks Moving in Wednesday's Pre-Market Session
December 15, 2021
From Benzinga
The Daily Biotech Pulse: Lilly Sings Metabolic Disorder Drug Pact, Moderna Reports Positive Flu Vaccine Data, Halozyme To Buy Back Shares
December 10, 2021
From Benzinga
The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO
December 09, 2021
From Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
From Benzinga
BeiGene - EUSA Pharma's Siltuximab Approved In China For Multicentric Castleman Disease
December 03, 2021
Tickers
BGNE
From Benzinga
The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering
December 03, 2021
From Benzinga
The Daily Biotech Pulse: Kura's Blood Cancer Drug Study Gets Partial Clinical Hold, Takeda FDA Nod, Puma Breast Cancer Treatment Gets Patent Extension
November 24, 2021
From Benzinga
BeiGene's Brukinsa Approved In Europe For Rare Type Of Blood Cancer
November 24, 2021
Tickers
BGNE
From Benzinga
2 Growth Stocks That Could Deliver 1,000% Returns
October 31, 2021
From Motley Fool
2 Penny Stocks That Could Soar Soon
October 14, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2021
October 12, 2021
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
3 Biotech Stocks That Surged in September
October 05, 2021
From Motley Fool
This Potential Indication Could Be a Winner for Novartis
September 29, 2021
From Motley Fool
Notable Beigene Insider Trades $3.11 Million In Company Stock
September 23, 2021
Tickers
BGNE
From Benzinga
48 Biggest Movers From Friday
September 20, 2021
From Benzinga
Why BeiGene's Shares Jumped on Friday
September 17, 2021
From Motley Fool
Beigene Insider Trades $33.79 Million In Company Stock
September 17, 2021
Tickers
BGNE
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 17, 2021
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
September 17, 2021
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.